VDR and neoplasm: These findings suggest a particular anti-tumor potential that is independent of the specifications of tumor cells, as VDR is also active in fibroblasts, and a “timing hypothesis”, since the susceptibility of cancer cells to VDR might largely depend on the tumor stage.